A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial
基于 Pfs48/45 的疫苗阻断恶性疟原虫传播:1 期开放标签临床试验
期刊:BMC Medicine
影响因子:7
doi:10.1186/s12916-024-03379-y
M Alkema, M J Smit, C Marin-Mogollon #, K Totté #, K Teelen, G J van Gemert, M van de Vegte-Bolmer, B G Mordmüller, J M Reimer, K L Lövgren-Bengtsson, R W Sauerwein, T Bousema, J Plieskatt, M Theisen, M M Jore, M B B McCall